Intracoronary administration of microencapsulated IGF-1 improves cardiac function and reduces myocardial fibrosis in a porcine model of acute myocardial infarction
Por:
Diaz, CCB, Blazquez, VB, Margallo, FMS, Monton, CG, Gonzalez, I, Abad, A, Steendam, R, Franssen, O, Palacios, I, Bayes-Genis, A and Crisostomo, V
Publicada:
1 sep 2020
Resumen:
Filiaciones:
Diaz, CCB:
CIBERCV CCMIJU, Madrid, Spain
Blazquez, VB:
Jesus Uson Minimally Invas Surg Ctr, Caceres, Spain
Margallo, FMS:
Jesus Uson Minimally Invas Surg Ctr, Caceres, Spain
:
Hlth Sci Res Inst Germans Trias & Pujol IGTP, Badalona, Spain
Gonzalez, I:
Jesus Uson Minimally Invas Surg Ctr, Caceres, Spain
Abad, A:
Jesus Uson Minimally Invas Surg Ctr, Caceres, Spain
Steendam, R:
Innocore Pharmaceut, Groningen, Netherlands
Franssen, O:
Nanomi BV, Oldenzaal, Netherlands
Palacios, I:
Tigenix, Madrid, Spain
:
Hlth Sci Res Inst Germans Trias & Pujol IGTP, Badalona, Spain
Crisostomo, V:
Jesus Uson Minimally Invas Surg Ctr, Caceres, Spain
|